Seattle Genetics Backtesting

SGEN -- USA Stock  

USD 65.11  0.64  0.97%

With this equity back-testing module your can estimate the performance of a buy and hold strategy of Seattle Genetics and determine expected loss or profit from investing in Seattle Genetics over given investment horizon. Also please take a look at Seattle Genetics Hype Analysis, Seattle Genetics Correlation, Seattle Genetics Valuation, Seattle Genetics Volatility as well as analyze Seattle Genetics Alpha and Beta and Seattle Genetics Performance.
 Time Horizon     30 Days    Login   to change

Seattle Genetics 'What if' Analysis

May 20, 2018
No Change 0.00  0.0%
In 30 days
June 19, 2018
If you would invest  0.00  in Seattle Genetics on May 20, 2018 and sell it all today you would earn a total of 0.00 from holding Seattle Genetics or generate 0.0% return on investment in Seattle Genetics over 30 days. Seattle Genetics is related to or competes with Vertex Pharmaceuticals, Endo International, Abbott Laboratories, Allergan plc, Bio Rad, Bristol Myers, and LILLY ELI. Seattle Genetics, Inc., a biotechnology company, focuses on the development and commercialization of targeted therapies ...

Seattle Genetics Upside/Downside Indicators

Downside Deviation1.68
Information Ratio0.2845
Maximum Drawdown10.3
Value At Risk2.43
Potential Upside3.7

Seattle Genetics Market Premium Indicators

Risk Adjusted Performance0.01
Sortino Ratio0.3875

Seattle Genetics Backtested Returns

Macroaxis considers Seattle Genetics not too volatile given 1 month investment horizon. Seattle Genetics owns Efficiency Ratio (i.e. Sharpe Ratio) of 0.3932 which indicates Seattle Genetics had 0.3932% of return per unit of risk over the last 1 month. Our philosophy towards measuring volatility of a stock is to use all available market data together with company specific technical indicators that cannot be diversified away. By inspecting Seattle Genetics technical indicators you can presently evaluate if the expected return of 0.8847% is justified by implied risk. Please operate Seattle Genetics Semi Deviation of 1.19, Coefficient Of Variation of 351.54 and Risk Adjusted Performance of 0.01 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100 Seattle Genetics holds performance score of 26. The entity has beta of 0.0 which indicates the returns on MARKET and Seattle Genetics are completely uncorrelated. Although it is vital to follow to Seattle Genetics current price movements, it is good to be conservative about what you can actually do with the information regarding equity historical returns. The philosophy towards measuring future performance of any stock is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators. We have found twenty-one technical indicators for Seattle Genetics which you can use to evaluate performance of the company. Please operates Seattle Genetics Variance as well as the relationship between Value At Risk and Skewness to make a quick decision on weather Seattle Genetics existing price patterns will revert.
Advice Volatility Trend Exposure Correlations
15 days auto-correlation 0.29 

Poor predictability

Seattle Genetics has poor predictability. Overlapping area represents the amount of predictability between Seattle Genetics time series from May 20, 2018 to June 4, 2018 and June 4, 2018 to June 19, 2018. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Seattle Genetics price movement. The serial correlation of 0.29 indicates that nearly 29.0% of current Seattle Genetics price fluctuation can be explain by its past prices.
Correlation Coefficient 0.29
Spearman Rank Test 0.3
Price Variance 4.41
Lagged Price Variance 6.74

Seattle Genetics lagged returns against current returns

 Current and Lagged Values 

Seattle Genetics regressed lagged prices vs. current prices

 Current vs Lagged Prices 

Seattle Genetics Lagged Returns

 Regressed Prices 

Did you try this?

Run Portfolio Reporting Now

Portfolio Reporting

Create custom reports across your portfolios and generate quick suggestion pitch
All  Next Launch Portfolio Reporting

Trending Equities

Currently Active Assets on Macroaxis
Purchased over 100 shares of
few days ago
Traded for 10.44
Purchased over 300 shares of
few days ago
Traded for 6.24
Purchased over 70 shares of
few days ago
Traded for 23.42
Purchased over 200 shares of
few days ago
Traded for 8.1
Purchased over 400 shares of
few days ago
Traded for 4.74
Also please take a look at Seattle Genetics Hype Analysis, Seattle Genetics Correlation, Seattle Genetics Valuation, Seattle Genetics Volatility as well as analyze Seattle Genetics Alpha and Beta and Seattle Genetics Performance. Please also try Price Ceiling Movement module to calculate and plot price ceiling movement for different equity instruments.